General
Preferred name
ACECLOFENAC
Synonyms
Preservex ()
Airtal ()
Preservex, Airtal ()
Aceclofenac betadex ()
Aceclofenaco ()
Gerbin ()
Aceclofenac-d4 ()
P&D ID
PD001298
CAS
89796-99-6
2748492-20-6
Tags
available
drug
Approved by
FDA
Drug indication
rheumatic disease
Inflammation
Drug Status
approved
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
PRICE 29
DESCRIPTION Aceclofenac is an orally active nonsteroidal anti-inflammatory agent (NSAID), with analgesic and anti-inflammatory properties. Aceclofenac is used for the research of osteoarthritis, ankylosing spondylitis, rheumatoid arthritis[1][2].
DESCRIPTION Aceclofenac (Preservex) is a non-steroidal anti-inflammatory drug (NSAID) with marked anti-inflammatory and analgesic properties. (TargetMol Bioactive Compound Library)
Compound Sets
18
Cayman Chemical Bioactives
28620
43487
ChEMBL Drugs
CHEMBL93645
Drug Repurposing Hub
DrugBank
DB06736
DrugBank Approved Drugs
DB06736
DrugCentral
43
DrugCentral Approved Drugs
43
DrugMAP
DMZDF0B
DrugMAP Approved Drugs
DMZDF0B
DrugMatrix
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL93645
MedChem Express Bioactive Compound Library
HY-B0634
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
aceclofenac
TargetMol Bioactive Compound Library
T1421
The Spectrum Collection
External IDs
32
Properties
(calculated by RDKit )
Molecular Weight
353.02
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
2
Aromatic Ring Count
2
cLogP
3.91
TPSA
75.63
Fraction CSP3
0.12
Chiral centers
0.0
Largest ring
6.0
QED
0.77
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
COX
PTGS2
Immunology & Inflammation related
Indication
rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, periarthritis, lumbago, ischiadynia
MOA
prostanoid receptor antagonist
Pathway
Immunology/Inflammation
Neuroscience
Source data